Randomised, Multicentre Clinical Trial Found That Hypertonic Saline Did Not Reduce the Length of Stay of Hospitalised Patients With Acute Bronchiolitis.

Acta PaediatrJun 3, 2026 (epub)
Clinical ResearchPediatrics

Sara Szupieńko-Bujak, Karolina Bojarska-Cikoto, Katarzyna Merdzik et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the effectiveness of nebulised hypertonic saline compared to normal saline in 181 hospitalized infants with acute bronchiolitis. The study found no significant difference in the length of hospital stay, with a mean difference of -0.11 days (p=0.3).

Key findings

  • Median hospital stay was 2.68 days for hypertonic saline vs 2.79 days for normal saline.
  • No differences in clinical severity scores were observed between the two groups.
  • Readmissions occurred only in the normal saline group at a rate of 5.9%.

Why it matters

Understanding the effectiveness of treatments for bronchiolitis is crucial, as this condition is a leading cause of hospitalization in young children. This study suggests that hypertonic saline may not provide the expected benefits.

Source

Published in Acta Paediatr. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.